These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1605605)

  • 1. Use of norfloxacin to study colonization ability of Escherichia coli in in vivo and in vitro models of the porcine gut.
    Nielsen EM; Schlundt J
    Antimicrob Agents Chemother; 1992 Feb; 36(2):401-7. PubMed ID: 1605605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacin.
    Forsgren A; Striby AC
    Scand J Infect Dis; 1988; 20(5):531-4. PubMed ID: 3065926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolones and colonization resistance in human volunteers.
    Van Saene JJ; Van Saene HK; Geitz JN; Tarko-Smit NJ; Lerk CF
    Pharm Weekbl Sci; 1986 Feb; 8(1):67-71. PubMed ID: 2938072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Simple
    Mokszycki ME; Leatham-Jensen M; Steffensen JL; Zhang Y; Krogfelt KA; Caldwell ME; Conway T; Cohen PS
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30291119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.
    Pecquet S; Andremont A; Tancrède C
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1047-52. PubMed ID: 3729360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of norfloxacin and other antibacterial agents against gastro-intestinal pathogens isolated in Sweden.
    Olsson-Liljequist B; Möllby R
    APMIS; 1990 Feb; 98(2):150-5. PubMed ID: 2302351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Hooper DC; Wolfson JS; Souza KS; Tung C; McHugh GL; Swartz MN
    Antimicrob Agents Chemother; 1986 Apr; 29(4):639-44. PubMed ID: 3010850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract.
    Goldstein EJ; Citron DM; Corrado ML
    Am J Med; 1987 Jun; 82(6B):84-7. PubMed ID: 3300317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colonization of methicillin-resistant Staphylococcus aureus in the mouse intestinal tract].
    Tani K
    Nihon Saikingaku Zasshi; 1997 Apr; 52(2):493-503. PubMed ID: 9155206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
    Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
    Hirai K; Aoyama H; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Aug; 30(2):248-53. PubMed ID: 3532944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
    Piffaretti JC; Demarta A; Leidi-Bulla L; Peduzzi R
    Eur J Clin Microbiol; 1983 Dec; 2(6):600-1. PubMed ID: 6230227
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of persistence and transfer of genetic material by recombinant Escherichia coli in conventional, antibiotic-treated mice.
    Yancey RJ; Kotarski SF; Thurn KK; Lepley RA; Mott JE
    J Ind Microbiol; 1993 Jul; 11(4):259-71. PubMed ID: 7763898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
    Frimodt-Møller PC; Jensen KM; Madsen PO
    Antimicrob Agents Chemother; 1983 Oct; 24(4):560-3. PubMed ID: 6228191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial responses of Yersinia enterocolitica isolates in comparison to other commonly encountered bacteria that causes diarrhoea.
    Andualem B; Geyid A
    East Afr Med J; 2005 May; 82(5):241-6. PubMed ID: 16119753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.
    Aparicio JR; Such J; Pascual S; Arroyo A; Plazas J; Girona E; Gutiérrez A; de Vera F; Palazón JM; Carnicer F; Pérez-Mateo M
    J Hepatol; 1999 Aug; 31(2):277-83. PubMed ID: 10453941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of rifampin-resistant Escherichia coli to colonize the mouse intestine is enhanced by the presence of a plasmid-encoded aerobactin-iron(III) uptake system.
    Stojiljković I; Cobeljić M; Trgovcević Z; Salaj-Smic E
    FEMS Microbiol Lett; 1991 Dec; 69(1):89-93. PubMed ID: 1783288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis.
    Greenwood D
    J Antimicrob Chemother; 1984 May; 13 Suppl B():43-8. PubMed ID: 6234274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.